Literature DB >> 30224870

The validity and Reliability of the Turkish Version of Drug Attitude Inventory-10.

Emine Aydin1, Erkan Aydin2, Özlem Devrim Balaban3, Hüseyin Yumrukçal4, Murat Erkiran1.   

Abstract

INTRODUCTION: Compliance with drug treatment is an important issue in schizophrenia for which many scales have been devised. Turkish version of the Drug Attitude Inventory is frequently employed due to ease of use and high predictive value, although it is not as accurate as blood level testing.To determine the validity and reliability of the Turkish version of the Drug Attitude Inventory-10.
METHODS: Eighty-two schizophrenia patients were included in the study. Subjects were evaluated using Drug Attitude Inventory-10, a Sociodemographic Data Form, Positive and Negative Symptom Scale PANNS, Social Functioning Scale, and Quality of Life Scale for schizophrenia patients.
RESULTS: Reliability analysis revealed Cronbach's α coefficient for internal consistency to be 0.798 and item-total item correlation coefficients to be between 0.420 and 0.647. Test-retest correlation coefficient (r) was 0.809. Construct validity analysis revealed a tri-factorial construct which accounts for 62.68% of variance. Good conformity to single factor construct was found with confirmatory factor analysis.
CONCLUSION: Turkish version of the Drug Attitude Inventory-10 is valid and reliable for evaluation of schizophrenia patients which makes it suitable for research and clinical settings.

Entities:  

Keywords:  Drug attitude inventory; schizophrenia; treatment compliance

Year:  2018        PMID: 30224870      PMCID: PMC6138220          DOI: 10.5152/npa.2017.18078

Source DB:  PubMed          Journal:  Noro Psikiyatr Ars        ISSN: 1300-0667            Impact factor:   1.339


  17 in total

1.  Reliability and validity of a new Medication Adherence Rating Scale (MARS) for the psychoses.

Authors:  K Thompson; J Kulkarni; A A Sergejew
Journal:  Schizophr Res       Date:  2000-05-05       Impact factor: 4.939

2.  DAI-10 is as good as DAI-30 in schizophrenia.

Authors:  René Ernst Nielsen; Eva Lindström; Jimmi Nielsen; Sten Levander
Journal:  Eur Neuropsychopharmacol       Date:  2012-03-21       Impact factor: 4.600

Review 3.  Medication adherence in schizophrenia.

Authors:  Francisco Javier Acosta; José Luis Hernández; José Pereira; Judit Herrera; Carlos J Rodríguez
Journal:  World J Psychiatry       Date:  2012-10-22

4.  The Social Functioning Scale. The development and validation of a new scale of social adjustment for use in family intervention programmes with schizophrenic patients.

Authors:  M Birchwood; J Smith; R Cochrane; S Wetton; S Copestake
Journal:  Br J Psychiatry       Date:  1990-12       Impact factor: 9.319

5.  Attitudes towards neuroleptic treatment: reliability and validity of the attitudes towards neuroleptic treatment (ANT) questionnaire.

Authors:  O Kampman; K Lehtinen; V Lassila; E Leinonen; O Poutanen; A Koivisto
Journal:  Schizophr Res       Date:  2000-10-27       Impact factor: 4.939

6.  Drug attitude and other predictors of medication adherence in schizophrenia: 12 months of electronic monitoring (MEMS(®)) in the Swedish COAST-study.

Authors:  Cecilia Brain; Katarina Allerby; Birgitta Sameby; Patrick Quinlan; Erik Joas; Ulla Karilampi; Eva Lindström; Jonas Eberhard; Tom Burns; Margda Waern
Journal:  Eur Neuropsychopharmacol       Date:  2013-09-19       Impact factor: 4.600

7.  Collaboration in outpatient antipsychotic drug treatment: analysis of potentially influencing factors.

Authors:  Stefan Klingberg; Sabine Schneider; Andreas Wittorf; Gerhard Buchkremer; Georg Wiedemann
Journal:  Psychiatry Res       Date:  2008-10-14       Impact factor: 3.222

8.  A modified Drug Attitude Inventory used in long-term patients in sheltered housing.

Authors:  Sigrid Stjernswärd; Karin Persson; René Nielsen; Eva Tuninger; Sten Levander
Journal:  Eur Neuropsychopharmacol       Date:  2012-12-21       Impact factor: 4.600

9.  [Assessment of drug attitudes in patients with schizophrenia: psychometric properties of the DAI Spanish version].

Authors:  R Robles García; V Salazar Alvarado; F Páez Agraz; F Ramírez Barreto
Journal:  Actas Esp Psiquiatr       Date:  2004 May-Jun       Impact factor: 1.196

10.  Attitudes toward medication and the clinical variables in schizophrenia: Structural equation models.

Authors:  Alessandro Rossi; Roberta Pacifico; Paolo Stratta
Journal:  Patient Prefer Adherence       Date:  2009-11-03       Impact factor: 2.711

View more
  2 in total

1.  Attitude Towards Drug Therapy in a Community Mental Health Center Evaluated by the Drug Attitude Inventory.

Authors:  Rosaria Di Lorenzo; Daniela Perrone; Anushree Montorsi; Jessica Balducci; Sergio Rovesti; Paola Ferri
Journal:  Patient Prefer Adherence       Date:  2020-06-17       Impact factor: 2.711

Review 2.  Psychometric properties of Drug Attitude Inventory among patients with schizophrenia.

Authors:  Oladipo A Sowunmi
Journal:  S Afr J Psychiatr       Date:  2022-04-29       Impact factor: 1.242

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.